Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 9157-9168 of 17733

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

LactoSens®, Industry Gold Standard Biosensor Kit. Developed and manufactured by DirectSens in Vienna, AUSTRIA, © DirectSens GmbH 2024

DirectSens’ Market-Leading LactoSens® Biosensor Technology Acquired by Kerry Group P.L.C.

Technology Holdings Has Expanded Operations into Brazil, Driving Growth in Latin America

EUMETSAT: Lisbon Event Offers a Deep Dive Into Ocean Data

Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927

Hairlust Drives Rapid International Growth with nShift

Adtran’s technology is helping CRIANN drive high-speed, secure and ultra-reliable connectivity throughout its research and education network. (Photo: Business Wire)

CRIANN boosts bandwidth in French research and education network with Adtran FSP 3000

RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplasia Demonstrating Increase in Annualized Growth Rate of up to +4.6 cm/year in Children 5 Years of Age and Older in the Low Dose Cohort

Business Wire

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

DirectSens’ Market-Leading LactoSens® Biosensor Technology Acquired by Kerry Group P.L.C.

Technology Holdings Has Expanded Operations into Brazil, Driving Growth in Latin America

EUMETSAT: Lisbon Event Offers a Deep Dive Into Ocean Data

Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927

Hairlust Drives Rapid International Growth with nShift

CRIANN boosts bandwidth in French research and education network with Adtran FSP 3000

RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplasia Demonstrating Increase in Annualized Growth Rate of up to +4.6 cm/year in Children 5 Years of Age and Older in the Low Dose Cohort

BearingPoint announces Matthias Loebich as its Managing Partner

Infleqtion Expands Operations in Oxford, Underscoring Foundational Role in UK’s Quantum Future

J.C. Flowers Acquires Pepper Advantage from Pepper Global

Intel 471 Releases Report to Help Europe’s Critical Entities Navigate the Network and Information Security Directive (NIS2)